Kaiser Permanente chairman and chief executive officer Bernard J. Tyson dies at 60; vitamin E acetate is linked as a potential cause of vaping-related lung injuries; Medicare’s outpatient premium cost is rising.
Bernard J. Tyson, chairman and chief executive officer (CEO) of the health plan provider Kaiser Permanente, died unexpectedly in his sleep yesterday at the age of 60, reported USA Today. The news came after Tyson had spoken 1 day earlier at a tech gathering called AfroTech in Oakland, California. Kaiser Permanente issued a statement late Sunday evening stating, “On behalf of our Board of Directors, employees, and physicians, we extend our deepest sympathies to Bernard’s family during this very difficult time.” Tyson became the head of Kaiser Permanente in 2013 and had worked at the company for over 30 years.
Health officials at the CDC announced on Friday that there has been a breakthrough in the investigation of vaping-related lung injuries, as the chemical compound vitamin E acetate was found in all samples of lung fluid collected from 29 patients who were hospitalized for vaping, according to NPR. The vaping outbreak, which has led to the deaths of 39 people and sickened more than 2000 others, had been linked in hundreds of patients to the use of THC, the main psychoactive component of marijuana. Anne Schuchat, MD, CDC’s principal deputy director, told reporters on a press call that “vitamin E acetate is a known additive used to dilute liquid in e-cigarettes or vaping products that contain THC,” said Schuchat.
Medicare’s Part B premium for outpatient care is set to rise next year by nearly 7% to $144.60 a month next year, according to the Associated Press. Officials blamed the premium increase largely on rising spending for drugs administered in doctors’ offices, which are covered under the Part B outpatient benefit and include many cancer drugs. The $9.10 monthly increase follows a smaller $1.50 rise this year and comes after Social Security announced a modest cost-of-living raise for 2020 that comes out to approximately $24 a month for the average retired worker.
The Supreme Court seems likely to reject a challenge to the abortion pill mifepristone; the FDA is inspecting far fewer pharmaceutical companies conducting clinical research; AstraZeneca has sued to block an Arkansas law that it said would unlawfully expand the 340B program to include for profit-pharmacy chains.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Covered Preventive Services at Risk: V-BID Summit Breaks Down the Braidwood v Becerra Case
March 20th 2024For more than a decade, certain high-value preventive care services have been covered at no cost to patients under the Affordable Care Act, but a current legal challenge has the coverage at risk.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Most private health insurers have yet to publish criteria for when they will cover postpartum depression drug, zuranolone; state lawmakers are increasingly opposing health care mergers that they believe do not serve the public interest; Medicaid extensions made in 2021 led to a 40% decline in postpartum lack of insurance.
Read More
President Biden will preview his plan to more than double the size of Medicare’s new drug price negotiation program in the upcoming State of the Union address; Mexicans and Central Americans were most affected by the pandemic in terms of all-cause mortality; two Alabama fertility clinics said they expect to resume in vitro fertilization (IVF) services after a bill was passed to protect doctors.
Read More
The Supreme Court seems likely to reject a challenge to the abortion pill mifepristone; the FDA is inspecting far fewer pharmaceutical companies conducting clinical research; AstraZeneca has sued to block an Arkansas law that it said would unlawfully expand the 340B program to include for profit-pharmacy chains.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Covered Preventive Services at Risk: V-BID Summit Breaks Down the Braidwood v Becerra Case
March 20th 2024For more than a decade, certain high-value preventive care services have been covered at no cost to patients under the Affordable Care Act, but a current legal challenge has the coverage at risk.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Most private health insurers have yet to publish criteria for when they will cover postpartum depression drug, zuranolone; state lawmakers are increasingly opposing health care mergers that they believe do not serve the public interest; Medicaid extensions made in 2021 led to a 40% decline in postpartum lack of insurance.
Read More
President Biden will preview his plan to more than double the size of Medicare’s new drug price negotiation program in the upcoming State of the Union address; Mexicans and Central Americans were most affected by the pandemic in terms of all-cause mortality; two Alabama fertility clinics said they expect to resume in vitro fertilization (IVF) services after a bill was passed to protect doctors.
Read More
2 Commerce Drive
Cranbury, NJ 08512